Clinical Trials Directory

Trials / Completed

CompletedNCT04427059

A Study to Compare Two Techniques for Pain Control After Bariatric Surgery

Laparoscopic Assisted Transversus Abdominis Plane (TAP) Block Vs Local Anesthetic Infiltrations in Bariatric Surgery: a Prospective Randomized Double-Blind Controlled Trial (TAP BLOCK BARIATRIC TRIAL)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
115 (actual)
Sponsor
Fabio Garofalo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the postoperative pain and other clinical outcomes in patients who, during bariatric surgery, will be injected with a local anesthetic (Ropivacaine) through two different techniques.

Conditions

Interventions

TypeNameDescription
PROCEDURETransversus Abdominis Plane (TAP) blockThe laparoscopic-assisted Transversus Abdominis Plane (TAP) block will be done just after the optic trocar placement as follow: as landmarks we use the anterior axillary line, in the middle between the iliac crest and the costal margin. After insertion of the optic trocar the peritoneum is visualized. A 14 Gauge needle is inserted 2 cm cranially respect the taken landmark through the skin until the penetration of the internal and external oblique fascias, identified as sudden lowering of resistance. Laparoscopy allows to confirm that the needle did not pass the peritoneum. A solution of 20 ml of Ropivacaine (0.25%) is then injected, observing the formation of a bulge posterior to the transversus abdominis muscle. The procedure is then repeated identically on the contralateral side.
PROCEDUREPort-Site Infiltration (PSI)The Port-Site Infiltration (PSI) will be performed by infiltrating the subcutis and the skin at the trocar site before the trocar placements with a solution of local anesthetic (Ropivacaine 0.25%), a total of 40 ml will be administered.

Timeline

Start date
2020-06-15
Primary completion
2021-07-07
Completion
2021-07-07
First posted
2020-06-11
Last updated
2021-10-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04427059. Inclusion in this directory is not an endorsement.